Moderna, Inc. (MRNA)
49.66
+3.66
(+7.97%)
USD |
NASDAQ |
Jun 11, 16:00
49.43
-0.22
(-0.45%)
After-Hours: 19:13
Moderna Accounts Payable (Quarterly) : 161.00M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Accounts Payable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 161.00M |
| December 31, 2025 | 317.00M |
| September 30, 2025 | 267.00M |
| June 30, 2025 | 175.00M |
| March 31, 2025 | 226.00M |
| December 31, 2024 | 405.00M |
| September 30, 2024 | 373.00M |
| June 30, 2024 | 279.00M |
| March 31, 2024 | 183.00M |
| December 31, 2023 | 520.00M |
| September 30, 2023 | 494.00M |
| June 30, 2023 | 310.00M |
| March 31, 2023 | 389.00M |
| December 31, 2022 | 487.00M |
| September 30, 2022 | 330.00M |
| June 30, 2022 | 181.00M |
| March 31, 2022 | 199.00M |
| Date | Value |
|---|---|
| December 31, 2021 | 302.00M |
| September 30, 2021 | 87.00M |
| June 30, 2021 | 77.00M |
| March 31, 2021 | 8.00M |
| December 31, 2020 | 18.36M |
| September 30, 2020 | 20.52M |
| June 30, 2020 | 18.82M |
| March 31, 2020 | 11.03M |
| December 31, 2019 | 7.09M |
| September 30, 2019 | 11.74M |
| June 30, 2019 | 29.61M |
| March 31, 2019 | 38.51M |
| December 31, 2018 | 31.21M |
| September 30, 2018 | 24.36M |
| June 30, 2018 | |
| March 31, 2018 | |
| December 31, 2017 | 20.72M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| BioNTech SE | 540.15M |
| Sarepta Therapeutics, Inc. | 70.38M |
| Erasca, Inc. | 2.163M |
| Replimune Group, Inc. | 5.647M |
| Revolution Medicines, Inc. | 80.54M |